These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12387283)

  • 1. ACOG Committee Opinion: safety of Lovenox in pregnancy.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2002 Oct; 100(4):845-6. PubMed ID: 12387283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG committee opinion. Safety of Lovenox in pregnancy. Number 276, October 2002. Committee on Obstetric Practice.
    American College of Obsterticians and Gynecologists Committee on Obstetric Practice. Committee on Obstetric Practice
    Int J Gynaecol Obstet; 2002 Dec; 79(3):299-300. PubMed ID: 12501868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulants and pregnancy: when are they safe?
    Gibson PS; Powrie R
    Cleve Clin J Med; 2009 Feb; 76(2):113-27. PubMed ID: 19188477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
    Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
    Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].
    Barjot P; Beucher G; Le Querrec A; Derlon-Borel A; Herlicoviez M
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):544-9. PubMed ID: 10598348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
    Descarries LM; Leduc L; Khairy P; Mercier LA
    J Heart Valve Dis; 2006 Sep; 15(5):679-85. PubMed ID: 17044374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients.
    Seshadri N; Goldhaber SZ; Elkayam U; Grimm RA; Groce JB; Heit JA; Spinler SA; Turpie AG; Bosker G; Klein AL
    Am Heart J; 2005 Jul; 150(1):27-34. PubMed ID: 16084147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of thromboembolism in pregnancy.
    Marks PW
    Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic heart valves and pregnancy.
    McLintock C; North RA; White HD
    Circulation; 2003 Dec; 108(23):e159-60; author reply e159-60. PubMed ID: 14662695
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of low molecular weight heparin therapy during labor.
    Maslovitz S; Many A; Landsberg JA; Varon D; Lessing JB; Kupferminc MJ
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):39-43. PubMed ID: 15804785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and anticoagulation in pregnancy: indications, risks and management.
    Montavon C; Hoesli I; Holzgreve W; Tsakiris DA
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):685-96. PubMed ID: 19012185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and management of venous thromboembolism in pregnancy.
    James AH
    Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin use during pregnancy.
    Houman MH; Ksontini-Smida I; Miled M
    Tunis Med; 2002 Jun; 80(6):297-305. PubMed ID: 12534039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy.
    Lebaudy C; Hulot JS; Amoura Z; Costedoat-Chalumeau N; Serreau R; Ankri A; Conard J; Cornet A; Dommergues M; Piette JC; Lechat P
    Clin Pharmacol Ther; 2008 Sep; 84(3):370-7. PubMed ID: 18431408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Xa activity with low-molecular-weight heparin, enoxaparin, during pregnancy in women with mechanical heart valves.
    Izaguirre R; De La Peña A; Ramírez A; Cortina E; Huerta M; Salazar E
    Proc West Pharmacol Soc; 2002; 45():127-8. PubMed ID: 12434554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.